Patel, K., Raymond, C., Yao, J., Tsung, J., Goldman, J., Schlossman, J., Tran, C., Brenner, A., Butowski, N., Wen, P., Pope, W., Ji, M., Lai, A., Leia Nghiemphu, P., Rachmilewitz Minei, T., Cohen, Y., Harats, D., Cloughesy, T., & Ellingson, B. (n.d.). nIMG-54. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM BEVACIZUMAB IN RECURRENT GLIOBLASTOMA WITH A LARGE TUMOR BURDEN: EVIDENCE FROM CLINICAL PRACTICE AND A MULTICENTER PHASE 3 TRIAL. Neuro-oncology, 21, vi173. http://access.bl.uk/ark:/81055/vdc_100094880467.0x00004f